Dr. Armin Alaedini leads study that finds individuals without celiac disease may have weakened intestinal barriers that lead to a body-wide inflammatory immune response.
The five-year grant from the National Center for Advancing Translational Sciences at the NIH is part of a multidisciplinary effort to speed the discovery and development of new medical therapies.
CUMC Executive Leadership announces the appointment of Dr. Muredach P. Reilly as director-designate of the Irving Institute, and thank Dr. Henry N. Ginsberg for his many years of exemplary leadership.
